Product Information
- trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide
- JAKi
- PF 03394197
Applications Oclacitinib is a novel Janus kinase (JAK) inhibitor with activity against cytokines involved in allergy.
References Gonzales, A.J., et al.: J. Vet. Pharmacol. Ther., 37, 317 (2014)
Chemical properties
Technical inquiry about: TR-O170000 Oclacitinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.